Crenezumab

South San Francisco-Based Genentech Starts Clinical Trial On Alzheimer’sGenentech is studying whether intervention can stop Alzheimer’s from developing in people genetically predisposed to the disease.

More From CBS San Francisco

Music's Biggest Night
Your Bay Area Guide To Valentine's Day

Listen Live